Pacemaker Market Outlook, Size, Share & Key Companies by 2032

 

Market summery -

Global Pacemaker Market Share is expected grow a CAGR of 3.60% over the forecast period of 2023-2032, as per the latest study report by Market Research Future (MRFR).

Pacemakers regularize heart rhythm by sending electric pulses to the heart and help in restoring cardiac activity. The surge in the prevalence of cardiac diseases has generated high demand for pacemakers which is driving the growth of the global pacemaker market. Atrial fibrillation, in particular, has witnessed a higher incidence rate in recent years which requires pacemakers for remediation. Increase in global geriatric population is also creating a conducive environment for the growth of the market. Atrial fibrillation and cardiac diseases are more prevalent in old patients. As per a 2018 study published in the Aging Medicine, there is 5 to 9% chance of occurrence of atrial fibrillation in patients between the age of 60-80 years and nearly 10% in patients aged over 80 years.

Technological advancements have resulted in the development of advanced pacemakers which are smaller in size and have longer battery life. Other factors aiding the growth of the market include an elevated level of awareness regarding cardiovascular diseases, improvement in reimbursement scenario, and high healthcare expenditure across the globe.

In recent years, various new pacemakers have received clearance from regulatory bodies which also has augmented the growth of the global pacemaker market. However, the approval and marketing if pacemakers are regulated by the US FDA which are stringent considering the degree of risk they pose to patients. Such stringent regulatory requirements might impede the growth of the market. High costs of pacemakers, risks involved in implantation procedures and risks of malfunctioning are other possible bottlenecks.

Competitive Landscape

Global pacemaker market players are below.

ZOLL Medical Corporation, MEDICO S.p.A, Cordis, Inc., St. Jude Medical Inc., Biotronik GmbH & Co. KG, Boston Scientific Corporation, General Electric Company, Pacetronix, Medtronic Plc, Sorin Group, Edwards Lifesciences, Cook, and Vitatron are the key players in the global pacemaker market.

Segmentation

The global pacemaker market outlook has been segmented based on product type, application, implant approach, and end-user.

By product type, the global pacemaker market has been segmented into implantable and external. The implantable segment has been further segmented into single chamber, dual chamber, and biventricular.

By application, the global pacemaker market has been segmented into bradycardia, heart failure, hypertrophic cardiomyopathy, syncope, and others. The bradycardia segment has been further segmented into sinus node dysfunction and AV block.

By implant approach, the global pacemaker market has been segmented into endocardial approach and epicardial approach.

By end-user, the global pacemaker market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

Regional Analysis

By region, the global pacemaker market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

The Americas account for the largest share of the global pacemaker market. Presence of a robust healthcare sector and technological advancements accelerate the growth of the market. The FDA has also been approving various novel pacemakers in the region. Moreover, the presence of various medical device manufacturers and surging cases of cardiovascular disorders support market growth in the Americas.

Europe follows the Americas closely and ranks second in the global pacemaker market. Growing government support in the form of R&D grants and the growing presence of key players in the region drive the market in Europe. The growing incidence rate of cardiovascular diseases and high healthcare expenditure are other factors substantiating the growth of the market.

APAC pacemaker market is driven by the growing prevalence of atrial fibrillation in the region. In addition, the region has emerged as a medical tourism hub which is likely to propel the growth of the market. Increasing healthcare expenditure and the presence of a large pool of cardiac patients also will have a positive impact on market growth.

The MEA market is likely to exhibit sluggish growth due to lack of healthcare infrastructure, lack of technical knowledge and less awareness regarding cardiac medical conditions.

Abut US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Robot-Assisted Surgical Systems Market Outlook: growth, drivers and forecast report by 2032

 

Market Overview

It is projected that the global robot-assisted surgical system market share is projected to reach at a CAGR 16.5% During the forecast period 2023-2032. Medical robotics technology is undergoing a tremendous transformation. Advancements in various fronts are being observed, which is providing an impetus to the application potential of healthcare robotics. The arrival of 3D imaging, HD surgical microscopic cameras, robotic catheter control system (CCS), data recorders & data analytics and remote navigation has enabled the undertaking of highly complex surgical produces.

The growing need for high surgical accuracy is driving the adoption of robot-assisted surgical systems. Moreover, an increased number of surgical procedures due factors such as a higher prevalence of trauma injuries, and rising geriatric population. Healthcare robotics boasts a strong R&D pipeline, which indicates towards a brighter future. Companies are actively focusing on devloping innovative products and their fast commercialization. For instanace, the US FDA approved Intuitive Surgical’s the da Vinci SP surgical system, which can be used in critical urologic surgical procedures in May 2018. However, the path is not without hurdles, high cost of such devices market customer pool limited. Product penetration remains sluggish in price-sensitive markets.

Global Robot-Assisted Surgical Systems Market: Competition Analysis

The Robot-Assisted Surgical Systems Market Players are Renishaw Plc, Stryker Corporation (MAKO Surgical Corp.), Accuracy, Health Robotics S.R.L.,Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Medtronic plc, Zimmer Biomet Holdings Inc., Verb Surgical,Titan Medical, Microbot Medical, Varian, Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Transenterix, KUKA AG, Medrobotics, Intuitive Surgical Inc, THINK Surgical Inc., and Mazor Robotics are among the key companies profiled in MRFR’s report.

Global Robot-Assisted Surgical Systems Market: Segmental Analysis

The segmental analysis of the global robot-assisted surgical systems market outlook has been conducted on the basis of end user, product, and application.

On the basis of end user, the market has been segmented into healthcare payers, healthcare providers and others. Based on product, the market has been segmented into rehabilitation robots, hospital and pharmacy robots, emergency response robotic systems, surgical robots and non-invasive radiosurgery robots. The rehabilitation robots segment covers prosthetics, therapeutic robots, robotic exoskeleton systems, orthotics and assistive robots. The hospital and pharmacy robots segment covers IV robots, cart transportation robots, pharmacy robots and telemedicine robots. The surgical robot segment covers laparoscopy robotic systems, robotic neurosurgical systems, and orthopedic surgical robots. Categories of laparoscopy robotics systems include Da Vinci robotic surgery system, Steerable Robotic Catheters, FreeHand endoscope holder system and Telelap ALF-X surgical system. Categories of robotic neurosurgical systems include NeuroMate surgical system, Renaissance surgical system and Pathfinder surgical system. Categories of orthopedic surgical robots include Robodoc surgical system, iBlock surgical system, MAKO RIO surgical system, Stanmore Sculptor surgical system and Navio PFS surgical system. On the basis of application, the market has been segmented into orthopedics robotic systems, special education, laparoscopy and neurology.

Global Robot-Assisted Surgical Systems Market: Regional Analysis

The regional analysis of the robot assisted surgical market insights has been conducted across the Middle East and Africa (MEA), Asia Pacific (APAC), Europe, and the Americas. In MEA, the market has been assessed in GCC countries and Africa. In APAC, countries such as China, Japan, India, South Korea, Australia, among others are covered. In the report, the Europe market has been segmented into Western and Eastern Europe. In West Europe, countries such as Germany, France, Italy, Spain, and the UK were under the spotlight. The Americas market has been segmented into Latin America and North America. In North America, the U.S. and Canada are covered.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

Pharmaceutical Sterility Testing Market Share, Insights and Forecast to 2032

 

Market Highlights

According to MRFR analysis, the global Pharmaceutical Sterility Testing Market Share is expected to register a CAGR of 6.10% from 2023 to 2032. Sterility can be defined as the non-appearance of viable microorganisms, dust, fibers, foreign particles, and other biological agents. Pharmaceutical sterility testing is performed on a wide range of biological medicinal products, including blood products, vaccines, biotechnology products, cell products, and tissue products, in accordance with WHO sterility requirements. Sterility testing is carried out by companies such as pharmaceutical companies, biotechnology companies, and medical device manufacturers to assess process control, raw material quality, and product validity.

The industry players focus on technological developments to dominate the global Pharmaceutical Sterility Testing Market. In addition, the key players are involved in new product launches, acquisitions, and joint ventures to augment their market positions. For instance, in July 2020, Neogen Corporation (US) has launched Soleris, an advanced test system that can rapidly detect a wide variety of microorganisms in a fraction of the time.

Key Players

Some of the Pharmaceutical Sterility Testing Market Players are.

§  Merck KGaA (Germany),

§  Rapid Micro Biosystems (US),

§  Sartorius AG (Germany),

§  Solvias AG (Switzerland),

§  SGS SA (Switzerland),

§  Boston Analytical (US),

§  bioMérieux, Inc. (France),

§  Charles River Laboratories International, Inc. (US),

§  Thermo Fisher Scientific, Inc. (US),

§  Pace Analytical Services, LLC (US),

§  Toxikon, Inc. (US),

§  Sotera Health (US),

§  Pacific Biolabs Inc. (US),

§  STRERIS Corporation (US),

§  WuXi AppTec (China).

Regional Analysis

North America is anticipated to dominate the global pharmaceutical sterility testing market outlook, owing to the presence of several key players in the region and the rise in R&D investments by public and private players in the healthcare sector. Moreover, the increase in the number of pipeline products and the launch of advanced drugs based on the biopharmaceutical that requires unique pharmaceutical sterility testing processes are also propelling the market growth.

The European pharmaceutical sterility testing market has been categorized into Germany, France, the UK, Italy, Spain, and the rest of Europe. Increasing government initiatives and extensive availability of research grants in the European countries are expected to propel the growth of the pharmaceutical sterility testing market in the region. Furthermore, the presence of outsourcing companies for pharmaceutical sterility testing is also supporting the growth of the pharmaceutical sterility testing market.

Asia-Pacific is anticipated to be the fastest-growing regional market over the forecast period due to the increasing harmonization of the regulatory standards with the International Council for Harmonisation (ICH) standards in developing nations, technological advances, and increasing investment in healthcare infrastructure. In addition, growing investment by governments from the China and India for offering cost-effective medications is providing lucrative opportunities for the growth of the pharmaceutical sterility testing market over the forecast period.

 In the Middle East, the UAE is the largest market due to the healthcare industry's development. Developing countries such as Argentina, Brazil, and Colombia, among others in Latin America, are also key contributors to the growth of the pharmaceutical sterility testing market insights.

Segmentation

The global sterility testing microbiology market has been segmented based on sample, product type, type, test type, and end user. By sample, the market has been segregated into sterile drugs, medical devices, and biologics. The sterile drugs segment is expected to witness high growth in 2020, Owing to the high adoption of several techniques adopted for product safety across the globe.

         ·         Based on product type, the global pharmaceutical sterility testing market has been classified into instruments, kits & reagents, and services. Kits & reagents held the largest segment share in 2020, owing to the repetitive purchase of these products by end users all around the world. In addition, cost efficiency and ease of use are related to the product.

         ·         Based on type, the global pharmaceutical sterility testing market has been classified into in-house and outsourcing.

         ·         Based on test type, the global pharmaceutical sterility testing market has been classified into sterility testing, bioburden testing, and bacterial endotoxin testing. The bacterial endotoxin testing segment held a major market share in 2020 due to the ongoing technological advancements in this segment.

·        Based on end user, the pharmaceutical sterility testing market is classified into compounding pharmacies, medical devices companies, pharmaceutical companies, and others. Pharmaceutical companies held the largest market share in 2020 due to the high growth of pharmaceutical and biological industries across the globe, and new drug approvals will boost the pharmaceutical sterility testing market during the forecasting period.

Related reports:

https://janjaonline.mn.co/posts/biologic-therapy-market-report-study-competitive-strategies-and-forecast

https://www.germanwomenorg.com/read-blog/431

https://www.danishwomenorg.com/read-blog/1063

 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Smart Pills Market Outlook, Size, Share & Key Companies by 2032

 

Market summery

Market Research Future (MRFR's) study on the global smart pills market share is projected to grow USD 2.01 billion by 2032 at a CAGR of 15.9% over the forecast period of 2023-2032. MRFR further asserts that the smart pills market is touted to reach USD 1,800 Mn by the end of 2032.

Amidst cut-throat competition, reimbursement issues, and expiry of blockbuster patent drugs, there is immense pressure on the healthcare sector to innovate diagnosis solutions. This has provided fuel for the advancement and commercialization of the smart pill technology which has been there for decades.

Smart pills are aligned with smart pills such as greater flexibility, precise delivery, real-time measurements, and monitoring of GI tract, and controlled operation or performance have acted as factors which can be employed to great advantage in drug development. They have several important applications, especially in diagnosis.

With the surge in the occurrence of chronic diseases, especially gastrointestinal diseases, smart pills are increasingly emerging as an effective method of endoscopy. Lifestyle diseases such as gastroesophageal reflux disease (GERD), obesity, and gastric ulcers are on the rise due to rapid lifestyle changes and unhealthy eating habits. This has induced high demand for on-site diagnosis, and, in turn, drive the market for smart pills. Surging prevalence of colon cancer is a key factor which is motivating the growth of the smart pills market.

Smart pills have been a breakthrough in gastrointestinal tract diagnosis and are set to replace conventional methods of diagnosis such as colonoscopy and endoscopy. Capsule endoscopy has cropped up as an effective method to perform endoscopy which is non-invasive and causes very little discomfort. Increasing consumer preference for minimally invasive medical procedures is likely to induce greater demand within the smart pills market.

Application of smart pills in monitoring pH, temperature, pressure, and drug adherence are further expected to catapult the growth of the market. Considerable research in the field of smart pills purveyed by heavy investments is also favoring the growth of the market. Other factors fostering market growth include conducive reimbursement landscape and increasing geriatric population. On the other hand, the market growth is restricted by factors such as regulatory restrictions and high costs of smart pills.

Competitive Landscape

Global smart pills market players are CapsoVision, Inc., Proteus Digital Health, Inc., JINSHAN Science & Technology, MEDTRONIC, Check-Cap, BDD Limited, Olympus Corporation, PENTAX Medical, FUJIFILM Holdings Corporation, MEDISAFE, INTROMEDIC, and RF Co., Ltd. are the notable players in the global smart pills market.

Segmentation

The global smart pills market has been segmented based on application, target area, disease indication, and end user.

 

By application, the smart pills market has been segmented into capsule endoscopy, drug delivery, patient monitoring, and others. The capsule endoscopy segment has been further segmented into small bowel capsule endoscopy, controllable capsule endoscopy, colon capsule endoscopy, and others. The patient monitoring segment has been further segmented into capsule pH monitoring and others.

By target area, the smart pills market has been segmented into esophagus, small intestine, large intestine, and stomach.

By disease indication, the smart pills market has been segmented into esophageal diseases, small bowel disases, colon diseases, and others.

By end user, the smart pills market has been segmented into hospitals, diagnostic center, and research institute.

Regional Analysis

By region, the smart pills market outlook has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

Conducive reimbursement scenario, the surging prevalence of chronic diseases, a nd fast uptake of advanced technology are the factors supporting the growth of the market in the region. The Americas account for the foremost share of the smart pills market.

Europe follows the Americas closely and accounts for the second most significant share of the smart pills market. Robust healthcare infrastructure, the high incidence rate of lifestyle-related diseases such as obesity, gastroesophageal reflux disease (GERD), and gastric ulcers have generated high demand for smart pills in the region. Moreover, European countries invest heavily in healthcare which acts as a plus for the growth of the market.

The APAC market is poised to perform relatively well and emerge as the fastest-growing market for smart pills. Percolation of advanced healthcare technologies in the region coupled with high healthcare expenditure in the developing countries of the region favors the growth of the market. Besides, increase in geriatric population and prevalence of various chronic diseases contribute to the growth of the market.

The minimum share of the smart pills market is held by MEA. Lack of knowledge, low healthcare penetration, and poor economic conditions, especially in the African region is hindering the growth of the market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Dental Surgical & Diagnostic Devices Market Share, Insights and Forecast to 2032

 

Market Analysis

The global dental surgical & diagnostics devices market size is projected to reach USD 11.33 Billion by 2032 at a CAGR of 8.2% over the forecast period of 2023-2032, reveals Market Research Future (MRFR) in a minutely analyzed research report.

Increasing prevalence of dental problems is the primary factor in boosting the growth of the market. Unhealthy eating habits among individuals result in tooth problems such as tooth decay, gum disease, cavities, etc. induce high demand for screening and treatment which drives the market for dental surgical and diagnostics devices. Increased affinity for cosmetic dentistry is also a notable factor influencing the growth of the market.

The rapid increase in global geriatric population is likely to fuel the growth of the global dental surgical & diagnostics market. The elderly populace is at more risk of suffering from dental problems more frequently than other age groups which generate demand for surgical and diagnostics products.

The growing trend of dental tourism has been instrumental in shaping the growth of the global dental surgical and diagnostics devices market. Healthcare costs mounting to unreasonable peaks in developed countries have encouraged dental tourism in developing countries such as India which augments the growth of the market.

The market is further propelled by developments made in the field of dental instruments, innovations in products and developments in surgical techniques which are anticipated to push the market ahead over the forecast period. Dental laser, oral radiology and other significant developments achieved in the field of dentistry along with the development of minimally invasive procedures have spurred market growth.

However, the growth of the market is likely to deter by the high cost of development, and lack of proper reimbursement policies. Procedures such as cosmetic dentistry are not covered under health policies and remains a significant obstacle for the growth of the global dental surgical & diagnostics devices market.

Competitive Landscape

Global dental surgical & diagnostics devices market players are A-dec Inc. (US), KaVo Kserr (US), Midmark Corp. (US), PLANMECA OY (Finland), American Medicals (US), Carestream Health (US), DCI (US), 3M (US), Danaher (US), GC Corporation (Japan), Hu-Friedy Mfg. Co., LLC (US), Ivoclar Vivadent AG (Liechtenstein), and Dentsply Sirona. (Germany) are the notable players operating in the dental surgical & diagnostics devices market.

Segmentation

The global dental surgical & diagnostics devices market has been segmented based on product type, application, and end users. By product type, the market has been segmented into CAD/CAM systems, dental chairs, dental radiology devices, CBCT scanners, scaling units, dental lasers. The CAD/CAM systems segment has been further segmented into full in-lab systems, stand-alone scanners, and chair-side systems.  The dental radiology devices market has been further segmented into Phosphor Storage Plates (PSP), digital x-ray, accessories, dental imaging devices. The dental lasers segment has been further segmented into soft tissue laser and all hard tissue laser market. The soft tissue laser sub-segment has been further segmented into gas laser, diode laser, and solid state lasers.

By application, the market has been segmented into bone abnormalities, cysts, fractures, reconstructive postmortem dental profiling, and comparative dental identification.

By end users, the market has been segmented into dentists, hospitals, and others.

Regional Analysis

The Americas, Europe, Asia Pacific, and the Middle East & Africa are the key markets for dental surgical & diagnostics devices. The Americas are at the forefront of the global dental surgical & diagnostics market insights. Presence of a vast pool of geriatric population, high expenditure on healthcare and well-developed healthcare infrastructure supports the growth of the market.

Europe is the second largest market for dental surgical & diagnostics devices driven by the outlay of massive amounts on the development of healthcare infrastructure.

Asia Pacific follows Europe closely and is slated to emerge as the fastest growing market. The Asia Pacific market stores ample growth opportunities owing to the presence of enormous population base, increasing awareness and growth of dental tourism in the region.

The Middle East & Africa market accounts for the least share of the market and is expected to exhibit sluggish growth over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cell Culture Media Market Outlook: SWOT Analysis, And Key Industry Developments

 

Cell Culture Media Market Overview:

The global cell culture media market share is projected to reach at a 14.21% CAGR during the forecast period 2023-2032. Over that period, it can also scale and surpass a valuation of USD 1290.1 million, reveals Market Research Future (MRFR). Cell culture media market is having a great run in the biotechnological sector owing to its prevalent use in the growth of microorganisms, cell lines, and cells. Available either in liquid or in gel form, the medium contains amino acids, inorganic salts, vitamins, glucose, serum, and other vital nutrients. However, the traction it is getting is mostly from the healthcare sector where it is often used to develop vaccines. The report includes detailed segmental analysis and description of factors that can impact the market the most. The keen interest shown by the biotechnological firms in studying plants and animals to develop drugs can be considered as a major factor. In healthcare, the demand for the customized drug is getting stronger by day which can spark further researches. In addition, it is the interest shown by governments that is influencing the market considerably.

On reverso, the cell culture media market can face certain blows owing to the considerable investment associated with it. The process incurs a massive cost which prevents smaller economies from participating in such researches. However, the growing involvement of India and China is saving the day. These two regions have relatively less workforce and establishment cost, which is making them alluring in the eyes of market titans who are now expanding their business in the region.

Cell Culture Media Market Competitive Analysis:

Cell culture media market players are HiMedia Laboratories (India), Thermo Fisher Scientific (U.S.), BD Biosciences (U.S.), Lonza (Switzerland), Corning Incorporated (U.S.), Merck KGaA (Germany), and GE Healthcare (U.S.).

CN Bio has developed a 3D cell culture system, PhysioMimix that allows researchers to set up assays and obtain results in faster. The process would allow scientists to mimic the structure and function of human organs for experiments.

Cell Culture Media Market Segmental Analysis:

The cell culture media market outlook, for better comprehension and predictive analysis, can be segmented by type, application, and end-user.

Based on type, the cell culture media market can be segmented into classical media, chemically defined media, protein-free media, lysogeny broth,serum-free media, and custom media. Lysogeny broth rules the market with 22.5% of the global share. Meanwhile, chemically defined media is touted to clock the fastest CAGR of 9.6% during the forecast period.

Based on application, the cell culture media market includes tissue engineering & biochemistry, cancer research, toxicity testing, drug discovery and drug development, genetic engineering, and stem cell research. With 23.8% of the total market share, drug discovery and drug development segment is treading ahead smoothly.

By end-users, the cell culture media market comprises research laboratories, academic institutes, biotechnology & pharmaceutical companies, and pathology labs. Biotechnology & pharmaceutical companies are leading the market at present with a worth of USD 386.5 million in 2016.

Cell Culture Media Market Regional Analysis:

Based on regional expansion, the cell culture media market insights includes the Americas, Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA).

The Americas has the biggest market, and this can be attributed to their superlative infrastructure, technological brilliance, and eagerness to integrate the latest developments in practice. The considerable patient pool in the region is also providing traction to the market growth. 

Europe is following the lead with great gusto. Increasing investment from the governments is helping the researchers plan accordingly, and the market is growing in sync with them. At the same time, the APAC region is doing a commendable job.  The market titans are engaging themselves in a battle over the APAC market as the region has a less infrastructural cost which makes it easier for others to settle in and do business. 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

 

 

Respiratory Therapeutic Devices Market Outlook, Size, Share & Key Companies by 2030

 Market Highlights 

The Respiratory Therapeutic Devices Market Share is anticipated to reach USD 12,231.6 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030. 

Respiratory therapeutic devices are used in the treatment, management, and control of cardiopulmonary diseases such as chronic obstructive pulmonary diseases (COPD), asthma, acute bronchitis, cystic fibrosis, and others. Increasing prevalence of asthma drives the market along with increasing per capita healthcare expenditure. According to the World Health Organization in 2017, approximately 235 million people have asthma. Moreover, it was estimated that in 2015, the diseases killed approximately 383 million patients around the globe. However, the market growth during the forecast period is likely to hamper due to low per capita income in the developing economies and lack of awareness.

Key Players

Global Respiratory Therapeutic Devices Market Players are

 

Masimo. (U.S.),

BD. (U.S.),

Smiths Group Plc. (U.S.),

F. Hoffmann-La Roche Ltd (Europe),

Bayer AG (Europe),

Rotech Healthcare Inc. (U.S.),

Chart Industries (U.S.),

Acare Technology (Asia Pacific), and

others.

Segmentation

The global respiratory therapeutic devices market outlook is segmented on the basis of product, technology, application, and end users.

On the basis of the product, the market is segmented into nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is sub-segmented into soft mist inhaler, human-powered nebulizer, and others. The capnography segment is sub-segmented into main-stream capnography, side-stream capnography, and others.

On the basis of the technology, the market is segmented into electrostatic filtration, HEPA filtration, hollow fiber filtration, microsphere separation, and others.

On the basis of the application, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, retail pharmacies, home care, and others. 

Regional Analysis

The Americas dominate the global respiratory therapeutic devices market insights owing to a huge patient population having cardiopulmonary diseases and well-developed healthcare sector. Moreover, the concentration of the global players like Masimo., BD., Smiths Group plc., besides others along with the increasing healthcare expenditure fuels the regional market growth during the forecast period. In 2015, according to the Centers for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. 

Europe is the second largest respiratory therapeutic devices market owing to a well-developed healthcare infrastructure, government support for research & development, and huge patient population. In 2017, according to a study published in the Asthma Research and Practice Journal, the total estimated cost per year for all the asthmatics per patient is about USD 1,900. 

Asia Pacific is the fastest growing market due to the presence of a huge patient population, continuously developing economies like India and China, and the presence of huge opportunities in the market. Moreover, favorable government policies and increasing healthcare expenditure fuel the market within the region. 

On the other hand, the Middle East & Africa holds the least share of the global respiratory therapeutic devices market due to the presence of poor economy, especially, within the African region. Majority of the market of this region is held by the Middle East due to the huge healthcare expenditure. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

Enteral Feeding Devices Market Share, Insights and Forecast to 2032

 

Market Overview

The global Enteral Feeding Devices Market share is predicted to meet the market value of USD 6.01 Billion by 2032 at a 5.10% CAGR for the forecast period of 2023 to 2032, according to the latest research report from Market Research Future (MRFR). The global enteral feeding devices market is profiled in detail in the report, which provides a comprehensive overview of the market’s leading drivers and restraints as well as the leading players operating in the market.

Enteral feeding devices are used to feed people who, permanently or temporarily, have lost the ability to feed themselves due to the disease or disorder. Enteral feeding devices are used to directly deliver nutrients into some part of the small intestine or stomach, so that at-risk patients can be fed under complete supervision. Enteral feeding devices also allow doctors to monitor and manage the temporary nutrition of specific individuals in order to make sure they are being fed as much and what they should be fed, considering specific diseases and disorders. The growing geriatric population around the world is likely to be a major driver for the global enteral feeding devices market over the forecast period, as the geriatric population is likely to be a major consumer of technologies that allow them to be fed without the hassle of physically feeding themselves. The growing number of geriatric individuals suffering from neurodegenerative diseases is also likely to be a major driver for the global Enteral Feeding Devices Market.

Competitive Analysis:

Leading Enteral Feeding Devices Market Players include:  

§  Medtronic plc,

§  Cook Medical,

§  B. Braun Melsungen AG,

§  Abbott Laboratories,

§  Boston Scientific Corporation,

§  Becton,

§  Dickinson and Company (BD),

§  Fresenius Kabi AG,

§  Danone Nutricia,

§  Nestlé,

§  CONMED Corporation,

§  Moog, Inc.,

§  Halyard Health, Inc., and

§  Vygon SA.

Segmentation:

The global enteral feeding devices market outlook has been segmented on the basis of product, age group, indication, end user, and region. 

·       By product, the market has been segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. The enteral feeding tubes segment is further categorized into enterostomy feeding tubes, nasoenteric feeding tubes, and oroenteric feeding tubes. The enterostomy feeding tubes segment is additionally divided into gastrostomy tubes, jejunostomy tubes, and gastrojejunostomy tubes. The nasoenteric feeding tubes segment is further classified into nasogastric feeding tubes, nasojejunal feeding tubes, and nasoduodenal feeding tubes. The enteral feeding pumps segment is expected to dominate the market throughout the forecast period due to low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing adoption of pumps in hospitals and home care settings.

·       On the basis of age group, the market has been divided into adults and pediatrics. 

·       By indication, the market has been classified into cancer, gastrointestinal diseases, diabetes, neurological disorders, hypermetabolism, and others. The cancer segment is further categorized into gastrointestinal cancer, head & neck cancer, liver cancer, pancreatic cancer, esophageal cancer, and others. 

·       Based on end user, the market has been categorized into hospitals, home care settings, and ambulatory surgery centers (ASCs). 

Major players in the global enteral feeding devices market  are likely to focus on developing products that fit regulatory standards and enable steady growth for the company in the market. The growing scope for the medical devices sector in Asia Pacific is likely to be a key factor for the global enteral feeding devices market over the forecast period. 

Regional Analysis:

The Americas dominates the global enteral feeding devices market, followed by Europe. Asia Pacific is also likely to grow at a high CAGR over the forecast period. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013               

Hair Removal Devices Market Share : A Technology Analysis of the Key Products & Applications

 

Overview:

The Hair Removal Devices Market Share exhibiting a compound annual growth rate (CAGR) of 9.8% during the forecast period (2023 - 2032). Market Research Future (MRFR) considers several factors like fashion, sports, cultural practices, military, medical reasons, and others as prominent growth-inducing avenues for the market. The easy availability of these products through retail and e-commerce lines strongly denotes hair removal devices market trends and better awareness regarding the product can boost the market prospect.

Competitive Landscape:

The global hair removal devices market players growth can benefit substantially from various companies like

Sciton, Inc,

Alma Lasers, Ltd.,

Syneron Medical Ltd.,

Cutera Inc.,

Cynosure, Inc.,

Lynton Lasers Ltd,

Solta Medical Inc.,

Strata Skin Sciences, Inc.,

Lumenis Ltd,

Lutronic Corporation, and

Venus Concept Canada Corp.

These companies have done research works and have set their own growth policies to establish a strong outcome for themselves. The global market is slated to benefit from their mergers, acquisitions, collaborations, hike in research activities, better investment in research and development projects, and others are expected to steer the market towards innovations. MRFR recorded these recent moves to get their hands on various prospects in the coming days.

Segmentation:

MRFR’s analysis of the global hair removal devices market outlook leads to an in-depth segmentation of product and end-user. These segments have multiple inputs from various factors that help in gaining insights and developing better marketing strategies.

·        By products, the global market for hair removal devices can be segmented into laser devices, intense pulse light (IPL) devices, energy-based devices, and others. The laser devices segment includes Nd: YAG laser, diode laser, and alexandrite laser. The laser devices segment had the maximum market share in 2017 and it is getting more traction from wider acceptance of the devices. The product is also performing better than other devices.

·        By end-users, the global report on the hair removal devices market comprises beauty clinics, home use, dermatology clinics, and others. The beauty clinics segment had the largest market share in 2017 owing to its huge women customer base.

Regional Analysis:

The Americas is expected to make huge profit in the coming years in the hair removal devices market. This is primarily due to the high investment capacity, better disposable income standards, increasing launch of innovative products, and others. The US and Canada are performing better. In Europe, this growth would be backed by the growing sale in France, Germany, Italy, Spain, and the UK. In Asia Pacific, China, India, Japan, and South Korea are expected to boost the market traction. 

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013